The alarms are starting to sound, and the time to buy cannabis stocks is now…

Kiplinger bills itself as the first magazine to bring sensible money-management advice to American investors.

And its focus remains the same 73 years later.

For the 4.5 million folks who visit its website, read its magazine, or peruse its newsletter, Kiplinger is a place to get advice about their money.

Advice that’s profitable, conservative, safe.

We’re talking about topics like:

  • The costs of downsizing your home in retirement.
  • Lists of tax-friendly states.
  • Money moves to make by year-end.
  • And the best dividend plays.

All straightforward. All pretty plain. All enduringly sensible.

So, when a high-profile, don’t-rock-the-boat magazine like Kiplinger makes a sudden foray into the world of cannabis investing, it’s jarring.

It’s also bullish – maybe even highly bullish…

I mean, just check out that headline! I took a screenshot as soon as I saw it.

Conservative Kiplingerhas officially put cannabis on its “radar” for the New Year.

This is more than just a headline, though.

It’s a “clue.”

Investing is a bit like being a detective, but instead of using clues to solve a mystery of the past, investors can use them to predict what’s going to happen next.

And I suspect you’ll soon be spotting a lot of different clues like this one from Kiplinger – clues that lead to only one prediction:

That cannabis stocks are being queued up for a rally more powerful than any you’ve ever seen.

Investors on the sidelines are watching, too – watching for more magazines, Wall Street analysts, CNBC “talking heads,” or local house brokers to tell them what to do.

All those folks will soon join Kiplinger to say, “buy cannabis.”

That flood of cash will ignite the rally in marijuana stocks.

And that’ll make a fortune for the early movers who were already invested.

Investors like you.

And while I will saw a handful of good investments on Kiplinger’s list, it missed a big one as the best marijuana stock to buy for 2021…

Make Sure to Add This to Your List of Best Cannabis Stocks to Buy in 2021

Over the last 18 months, I’ve gotten to know the team at Jushi Holdings Inc. (OTC: JUSHF) very well. And I’ve recently released a lot of key reports and updates about the company.

With a great brand, a strategic focus on what markets to enter, and a management team that’s all in on the company – the founders invested $45 million of their own money to get it started – Jushi promises to bring you big returns.

In fact, last week, I shared a three-episode series of my recent visit to Jushi’s newest dispensary in Santa Barbara, California:

Episode 1: Why Is Jushi One of the Best Stocks to Buy Right Now? It Starts With Going Beyond “Hello”

Episode 2: “You Have to Carry Top-Notch Flower”

Episode 3: The Sales Power Behind the Flower at Jushi

With each member of the team I speak with, you’ll quickly see why JUSHF is going to be such an incredible investment to buy ahead of 2021.

Because getting in early on a company like this is the key to the biggest gains – something our NICI Membership subscribers found out when they bought JUSHF shares in July for $1.52. As of this writing, that investment has climbed 100%!

That’s why I wanted to make sure you could access this information about a truly remarkable startup deal I’ve been working on. The CEO has already helped turn two other startups into billion-dollar companies, which made early shareholders a lot of money along the way.

Now, he’s doing the exact same thing with his new startup. Only this time, you are the one that has a chance to see an incredible 10 to 20-fold leap in the value of your investment, should you take advantage of this ground floor opportunity today.

You can click here to get all the details.

Take care,

Don Yocham

Executive Director, National Institute for Cannabis Investors


2 responses to “Make Sure This One Stock Is on Your Best Buy List for 2021”

  1. Any thoughts on Cresco Labs, They smashed earnings at 153 million for the quarter increasing 68% from last quarter.

    They almost caught up to Greenthumb but there Maket Cap is more than 1/2.

    Are we going to see Cresco double? Seems like no ones paying attention.

  2. Is Jushi still a good buy at double the price it was originally suggested to be bought at? Did we miss the boat?
    Thanks, Alex

Leave a Reply

Your email address will not be published. Required fields are marked *